Thermo Fisher Scientific Inc

Latest Results (25.02.2025):

Fourth Quarter Revenue Growth

Thermo Fisher Scientific Inc. reported a 5% increase in revenue for the fourth quarter of 2024, reaching $11.40 billion compared to $10.89 billion in the same quarter of 2023. This growth was driven by a 4% organic revenue increase and a 5% core organic revenue growth.

GAAP Earnings Performance

In the fourth quarter of 2024, Thermo Fisher Scientific Inc.'s GAAP diluted earnings per share (EPS) rose by 14% to $4.78, up from $4.20 in the previous year. The GAAP operating income for the quarter was $2.02 billion, with an operating margin of 17.7%, compared to 17.0% in the fourth quarter of 2023.

Adjusted Earnings Results

Thermo Fisher Scientific Inc. achieved an adjusted EPS of $6.10 in the fourth quarter of 2024, marking an 8% increase from $5.67 in the same period of 2023. The adjusted operating income for the quarter was $2.72 billion, with an adjusted operating margin of 23.9%, compared to 23.4% in the previous year.

Full Year Revenue and Earnings

For the full year 2024, Thermo Fisher Scientific Inc. reported revenue of $42.88 billion, remaining flat compared to $42.86 billion in 2023. The full year GAAP diluted EPS grew by 7% to $16.53, while the GAAP operating income increased to $7.34 billion, with an operating margin of 17.1%.

Capital Deployment and Shareholder Returns

Throughout 2024, Thermo Fisher Scientific Inc. successfully executed its capital deployment strategy, including the acquisition of Olink and returning $4.6 billion to shareholders through stock buybacks and dividends. This strategic approach contributed to the company's strong financial performance and shareholder value.